Inventaire - dine venner og fællesskaber er dit bedste bibliotek

Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trial

forfatter

Jean M. Fletcher

Cathal Walsh

2000 -

Michael Hutchinson

udgivet i: Trials

dato for udgivelse: 2013-08-27

main subject: placebo, vitamin D, vitamin, placebo-controlled trial, clinically isolated syndrome, study protocol

Cites articles 35

Date

Titel

Forfattere

2012-11-14

The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude

Gavin Giovannoni
2012

Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial

Friedemann Paul, Jan Dörr, Stephanie Ohlraun
2012-11-01

Vitamin D as a protective factor in multiple sclerosis.

Göran Hallmans
2012-03-28

A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers

Cathal Walsh, Michael Hutchinson, Sharee A Basdeo, Kingston H Mills, Jean M. Fletcher
2011-07-01

Gestational vitamin D and the risk of multiple sclerosis in offspring

Edward Giovannucci, Tanuja Chitnis, Alberto Ascherio, Éilis J. O'Reilly, Bernard A Rosner, Kassandra L Munger, Fariba Mirzaei, Karin B Michels, Michele R. Forman
2011-07

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

Michael F. Holick, Mohammad Murad, Heike A Bischoff-Ferrari, Robert P. Heaney, Connie Weaver
2011-05-28

Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial

Joost Smolders, Frederik Barkhof, Trygve Holmøy, Joep Killestein, Reinhold Vieth
2011-04-01

Relationship of UV exposure to prevalence of multiple sclerosis in England

Gavin Giovannoni
2011-04-08

Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

Ingrid van der Mei, Petr Otahal, Leigh Blizzard
2011-02

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Emmanuelle Waubant, Eva Havrdová, Alan J. Thompson, Massimo Filippi, Michael Hutchinson, Ludwig Kappos, Brian G Weinshenker, Chris Polman, Brenda L Banwell, Stephen C. Reingold, Kazuo Fujihara, Fred D. Lublin, Magnhild Sandberg-Wollheim, Jerry S Wolinsky
2011-02-01

Association of UV radiation with multiple sclerosis prevalence and sex ratio in France

Lucien Wald, George C. Ebers
2011-01-19

Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype

Patricia Fitzpatrick, Malachi J McKenna, Michael Hutchinson
2010-08-01

Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis

Ingrid van der Mei, Helen Tremlett, Leigh Blizzard, Anne-Louise Ponsonby, Terence Dwyer, Fotini Pittas
2010-04-28

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
2010-05-01

Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis

Emmanuelle Waubant, Jorge R. Oksenberg
2010-04-28

Clinically isolated syndrome: a protected zone for trials of new therapies?

Michael Hutchinson
2009-03-24

Immunomodulatory effects of Vitamin D in multiple sclerosis

María C Ysrraelit
2008-07-01

Control of autoimmune diseases by the vitamin D endocrine system

Giuseppe Penna
2008-03-01

Environmental factors and multiple sclerosis

George C. Ebers
2008-07-24

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.

Joost Smolders
2007-04-11

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

Helmut Butzkueven, Anne-Louise Ponsonby
2007-08-01

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.
2007-06-19

A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis
2006-04-01

Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards
2006-02-01

Prevalence of suboptimal vitamin D status in young, adult and elderly Irish subjects

Albert Flynn
2004-07-19

Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients

Amanda Hu, Reinhold Vieth
2004-01-15

Moderate beer consumption does not change early or mature atherosclerosis in mice

Laura Calpe-Berdiel, Joan Carles Escolà-Gil, Vicent Ribas, Francisco Blanco-vaca, Simone Lemieux
2003-01-01

Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol.

Michael F. Holick, Robert P. Heaney
2001-11-01

1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells

Andre Boonstra
1998-11-01

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group
1993-04-01

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group
1988-02-01

The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart.

Dallas R. English

Artikel - wd:Q37351726

Welcome to Inventaire

dit venne- og fællesskabs bibliotek

vil du vide mere